Inventor · disambiguated record
Laurence Anne Mevellec
Also filed as: MEVELLEC LAURENCE ANNE
30 granted patents·6 pending applications·165 citations·filing 2001–2023
96Inventor score
Files withJANSSEN PHARMACEUTICA NV20ASTEX THERAPEUTICS LTD5ANGIBAUD PATRICK RENE2VIALARD JORGE EDUARDO2Angibaud Patrick René1
Top patents by PatentIndex Score
36 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0394US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0490US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 0588US8299256B2Quinolinone derivatives as PARP and TANK inhibitorsVIALARD JORGE EDUARDO·Filed 2008·Granted Oct 30, 2012·17 cites·9 claims
- 0686US8404713B2Quinolinone derivatives as PARP inhibitorsANGIBAUD PATRICK RENE·Filed 2008·Granted Mar 26, 2013·10 cites·14 claims
- 0785US7803795B2Phthalazine derivatives as parp inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 28, 2010·7 cites·8 claims
- 0884US7173040B2Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Feb 6, 2007·21 cites·8 claims
- 0981US7196094B2Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Mar 27, 2007·11 cites·9 claims
- 1077US8946221B2Phthalazine derivatives as PARP inhibitorsMEVELLEC LAURENCE ANNE·Filed 2010·Granted Feb 3, 2015·5 cites·6 claims
- 1177US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1275US8778966B2Quinolinone derivatives as PARP and tank inhibitorsVIALARD JORGE EDUARDO·Filed 2012·Granted Jul 15, 2014·3 cites·6 claims
- 1374US8168644B2Quinazolinone derivatives as tubulin polymerization inhibitorsFREYNE EDDY JEAN EDGARD·Filed 2009·Granted May 1, 2012·2 cites·7 claims
- 1473US7652040B2Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonistsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jan 26, 2010·5 cites·10 claims
- 1573US7067531B2Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivativesANGIBAUD PATRICK RENE·Filed 2001·Granted Jun 27, 2006·6 cites·12 claims
- 1672US9150540B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 6, 2015·1 cites·8 claims
- 1768US8492377B2MTKI quinazoline derivativesPAPANIKOS ALEXANDRA·Filed 2007·Granted Jul 23, 2013·2 cites·15 claims
- 1868US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1967US8889866B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsAngibaud Patrick René·Filed 2009·Granted Nov 18, 2014·1 cites·8 claims
- 2065US7635706B25HT4-antagonistic 4-(aminomethyl)-piperidine benzamidesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Dec 22, 2009·2 cites·8 claims
- 2164US2025360142A1Novel atp-sensitive potassium channel potentiators, their preparation and useRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2261US8334304B2Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonistsBOSMANS JEAN-PAUL RENE MARIE ANDRE·Filed 2009·Granted Dec 18, 2012·0 cites·8 claims
- 2359US2015072972A1Phthalazine derivatives as parp inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Application pending·0 cites
- 2455US2024101554A1Cyclin-dependent kinase 7 (cdk7) non-covalent inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2550US12492194B2HPK1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 9, 2025·0 cites·15 claims
- 2650US12486264B2Bicyclic HPK1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 2, 2025·0 cites·23 claims
- 2748US9598396B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 21, 2017·0 cites·2 claims
- 2847US7732464B2Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonistsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jun 8, 2010·0 cites·10 claims
- 2947US7638535B24-(aminomethyl)-piperidine benzamides as 5HT4-antagonistsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Dec 29, 2009·0 cites·9 claims
- 3047US7498347B2Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Mar 3, 2009·0 cites·9 claims
- 3139US2019263804A1Azabenzimidazole derivatives as pi3k beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3238US10894793B2Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 19, 2021·0 cites·5 claims
- 3335US10202387B2Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 12, 2019·0 cites·14 claims
- 3435US10087187B2Imidazopyridazine derivatives as PI3KB inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 2, 2018·0 cites·14 claims
- 3532US10280170B2Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 7, 2019·0 cites·13 claims
- 3631US10342795B2Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives as ROS1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 9, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Laurence Anne Mevellec files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →